Zumutor Biologics Secures $7.3 Mn To Advance Clinical Trials For Cancer Therapy
Summary
Biotech startup Zumutor Biologics has raised $7.3 Mn (about ₹70 Cr) in its Series B funding round from existing investors…
Why It Matters
This Biotech development strengthens the region's biomanufacturing and life-sciences base. For India, it is a signal worth tracking: it shapes who supplies, who scales, and who sets the standard over the next five years.
Key Facts
- SectorBiotech
- MarketIndia
- ImpactMedium (58/100)
- SignalFunding